In this list of the top 10 med tech VC deals for Q3, one thing is painfully clear: Early-stage innovators are out of the picture. The winning companies are relatively far along, looking to expand...
An interesting thing happened on the way through 2013: Biotechnology venture investing began to see a healthy rebound in the second quarter, but medical device investing stayed essentially flat compared to the first three months of the year. Check out the report >>
Venture capital investment in medical device companies declined slightly during the 2013 second-quarter, even as it soared significantly for biotechnology and many other industries.
The VC industry turned in bleak numbers for biotech deal-making in the first quarter of 2013, with one key measure of early-stage activity in the life science sector falling to its lowest level in almost 18 years.
Med Tech venture investing continued its painful decline in the 2013 first quarter, dropping a whopping 20% in dollars and 10% in deal numbers versus last the three months of 2012, according to the latest MoneyTree survey.
In 2012, the medical device sector saw a 13% dollar-value drop from the year before and a 15% decline in the number of deals, according to the latest MoneyTree report. Read more >>
It's no secret--venture funding for medical device industries has become highly uneven at best. But the U.K.'s biggest charity outfit is stepping into the game, launching a £200 million ($325 million) fund that will help fill at least a few of the gaps.
The medical device industry tax and the Independent Payment Advisory Board--both major elements of the Affordable Care Act--stand a good shot at repeal in the coming months, according to a National Venture Capital Association analysis.
For the 2012 third quarter, the top venture capital funding rounds for medical device and equipment companies are anything but big. Noticeably, they're relatively small, peaking at just over $35 million and running far lower than that. Most are supplemental rounds.
Harvard Business School lecturer Shikhar Ghosh says that venture groups prefer a quiet funeral for their failures.